{"id":"NCT01600092","sponsor":"Merck Sharp & Dohme LLC","briefTitle":"A Study of the Immunogenicity, Tolerability, and Safety of a New Formulation of RotaTeq™ in Infants (V260-035)","officialTitle":"A Double-blind, Randomized, Controlled, Multicenter Study to Evaluate the Safety, Tolerability, and Immunogenicity of a New Formulation of RotaTeq™","status":"COMPLETED","phase":"PHASE3","dates":{"start":"2013-04-29","primaryCompletion":"2014-03-25","completion":"2014-03-25","firstPosted":"2012-05-16","resultsPosted":"2015-03-19","lastUpdate":"2018-11-14"},"enrollment":1020,"design":{"allocation":"RANDOMIZED","model":"PARALLEL","masking":"TRIPLE","primaryPurpose":"PREVENTION"},"conditions":["Rotavirus Gastroenteritis"],"interventions":[{"type":"BIOLOGICAL","name":"RotaTeq™ experimental formulation","otherNames":["V260"]},{"type":"BIOLOGICAL","name":"RotaTeq™ existing formulation","otherNames":["V260"]}],"arms":[{"label":"RotaTeq™ Experimental Formulation","type":"EXPERIMENTAL"},{"label":"RotaTeq™ Existing Formulation","type":"ACTIVE_COMPARATOR"}],"summary":"A study to compare safety, tolerability, and immunogenicity of a new formulation of RotaTeq™ with the existing formulation in infants. The primary hypothesis of the study is that the new formulation will be noninferior to the existing formulation on the basis of immunogenicity.","primaryOutcome":{"measure":"Geometric Mean Titer of Serum Neutralizing Antibody Response to Human Rotavirus Serotypes G1, G2, G3, G4, and P1A[8]","timeFrame":"42 days after vaccination 3 (up to 185 days)","effectByArm":[{"arm":"RotaTeq™ Experimental Formulation","deltaMin":99.8,"sd":null},{"arm":"RotaTeq™ Existing Formulation","deltaMin":106.1,"sd":null}],"pValues":[{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null},{"comp":"OG000 vs OG001","p":null}]},"eligibility":{"minAge":"6 Weeks","sex":"ALL","healthyVolunteers":true,"inclusionCount":1,"exclusionCount":10},"locations":{"siteCount":0,"countries":[]},"refs":{"pmids":["28141698"],"seeAlso":[]},"adverseEventsSummary":{"seriousAny":{"events":20,"n":508},"commonTop":["Diarrhoea","Pyrexia","Vomiting","Nasopharyngitis","Upper respiratory tract infection"]}}